We are navigators...
EUDRAC is a European specialised regulatory affairs and pharmacovigilance consultancy company providing support to our clients to drive products through development, registration, market launch and post-approval activities across all EU countries.
EUDRAC is based in Germany, France and the UK, since 2002.
About usLooking for support?
EUDRAC Ltd is extremely proud to have won a 2018 Queen’s Award for Enterprise in the International Trade category.
The Queen’s Awards for Enterprise are the UK’s most prestigious business awards, recognising and celebrating business excellence across the UK
Contact us, we are here to help you
Our customised packages aim to meet the needs requirements of both small and large healthcare companies. We have become valued and integral members of our clients’ project teams.
This has lead to a high level of repeat business and ongoing long–term assignments with our clients and is proof of the excellent service EUDRAC provides.
Contact us below to help you to achieve your goals!
ContactLatest from EUDRAC
-
Handling of pending Centralised Procedures during Brexit
The MHRA has recently published a guidance for handling of centrally authorised products (CAPs) with assessment pending on EU exit day. Although the...
Read more -
Brexit: Procedural Updates for Type I EMA variations
BREXIT: Procedural Updates for Type I EMA variations The EMA is strongly encouraging MAHs to be prepared for Brexit to occur by the 12th of April...
Read more -
Webinar: EU Labelling Requirements
Webinar: EU Labelling Requirements The EUDRAC team is presenting a TOPRA webinar on the linguistic review process at the end of March. We will share...
Read more